This Nature Biotechnology article introduces a novel trispecific macrophage engager (TrME) designed to overcome the limitations of current cancer immunotherapies in solid tumors. The researchers developed a molecular "AND" logic gate that simultaneously activates the prophagocytic LRP1 receptor and blocks the inhibitory SIRPα receptor on the same macrophage. By utilizing computationally guided des...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动